During the past decade, Hospital of the University of Pennsylvania Anticoagulation Management Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital of the University of Pennsylvania Anticoagulation Management Center" #1 collaborator was "Aetna, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital of the University of Pennsylvania Anticoagulation Management Center" are "Atrial Fibrillation" (3 trials), "Deep Vein Thrombosis" (2 trials), "Dilated Cardiomyopathies" (2 trials), "Deep Venous Thrombosis" (1 trials) and "Heart Valve Replacement" (1 trials). Many other conditions were trialed in "Hospital of the University of Pennsylvania Anticoagulation Management Center" in a lesser frequency.

Most popular intervention types in "Hospital of the University of Pennsylvania Anticoagulation Management Center" are "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "2Med-eMonitor" (1 trials), "Financial Incentive and Med-eMonitor" (1 trials), "Lottery arm (Lottery and Med-eMonitor)" (1 trials) and "Non-Lottery (Med-eMonitor only)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital of the University of Pennsylvania Anticoagulation Management Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital of the University of Pennsylvania Anticoagulation Management Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital of the University of Pennsylvania Anticoagulation Management Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital of the University of Pennsylvania Anticoagulation Management Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".